Works matching AU Mitsudomi, Tetsuya


Results: 131
    1
    2

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    3
    4
    5
    6

    Lung Cancer Working Group Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. suppl_1, p. i7, doi. 10.1093/jjco/hyq121
    By:
    • Saijo, Nagahiro;
    • Fukuoka, Masahiro;
    • Thongprasert, Sumitra;
    • Ichinose, Yukito;
    • Mitsudomi, Tetsuya;
    • Mok, Tony Shu Kam;
    • Ohe, Yuichiro;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
    By:
    • Yamaguchi, Masafumi;
    • Tada, Hirohito;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Yokoi, Kohei;
    • Katakami, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Oda, Makoto;
    • Ohta, Mitsunori;
    • Sawa, Toshiyuki;
    • Yamashita, Motohiro;
    • Iked, Norihiko;
    • Saka, Hideo;
    • Higashiyama, Masahiko;
    • Nomori, Hiroaki;
    • Semba, Hiroshi;
    • Negoro, Shunichi;
    • Chiba, Yasutaka;
    • Shimokawa, Mototsugu;
    • Fukuoka, Masahiro
    Publication type:
    Article
    26
    27
    28

    Neuroendocrine tumor metastasis to the thyroid gland.

    Published in:
    International Journal of Clinical Oncology, 2007, v. 12, n. 1, p. 63, doi. 10.1007/s10147-006-0628-8
    By:
    • Yamada, Hiroko;
    • Hasegawa, Yasuhisa;
    • Mitsudomi, Tetsuya;
    • Nakashima, Tsutomu;
    • Yatabe, Yasushi
    Publication type:
    Article
    29
    30

    Aggressive Pulmonary Metastasectomies for Synovial Sarcoma.

    Published in:
    Respiration, 1997, v. 64, n. 4, p. 316, doi. 10.1159/000196697
    By:
    • Maruyama, Rüchiroh;
    • Mitsudomi, Tetsuya;
    • Ishida, Teruyoshi;
    • Saitoh, Genkichi;
    • Nishioka, Kenichi;
    • Fukuyama, Yasuro;
    • Hamatake, Motoharu;
    • Sugio, Kenji;
    • Sugimachi, Keizo
    Publication type:
    Article
    31
    32
    33
    34

    MEK inhibitors against MET-amplified non-small cell lung cancer.

    Published in:
    International Journal of Oncology, 2016, v. 49, n. 6, p. 2236, doi. 10.3892/ijo.2016.3736
    By:
    • MASATO CHIBA;
    • YOSUKE TOGASHI;
    • SHUTA TOMIDA;
    • HIROSHI MIZUUCHI;
    • YU NAKAMURA;
    • ERI BANNO;
    • HIDETOSHI HAYASHI;
    • MASATO TERASHIMA;
    • DE VELASCO, MARCO A.;
    • KAZUKO SAKAI;
    • YOSHIHIKO FUJITA;
    • TETSUYA MITSUDOMI;
    • KAZUTO NISHIO
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Detection of Overlooked Rare EGFR Mutations in Non‐small Cell Lung Cancer Using Multigene Testing.

    Published in:
    Thoracic Cancer, 2025, v. 16, n. 3, p. 1, doi. 10.1111/1759-7714.70007
    By:
    • Shiraishi, Naoki;
    • Takahama, Takayuki;
    • Sakai, Kazuko;
    • Tanaka, Kaoru;
    • Nakagawa, Yuzuki;
    • Kanemura, Hiroaki;
    • Nakayama, Tomohiro;
    • Kawanaka, Yusuke;
    • Kurosaki, Takashi;
    • Suzuki, Shinichiro;
    • Iwasa, Tsutomu;
    • Tanizaki, Junko;
    • Inagaki, Chiaki;
    • Yonesaka, Kimio;
    • Fukuoka, Kazuya;
    • Mitsudomi, Tetsuya;
    • Nishio, Kazuto;
    • Hayashi, Hidetoshi;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    44
    45
    46
    47
    48

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    49
    50